Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Netupitant-Palonosetron Combination Shows Continued Superiority Over Palonosetron for CINV

June 27th 2014

A treatment intended to control chemotherapy-induced nausea and vomiting that combines netupitant and palonosetron demonstrated superior activity in complete response rates over oral palonosetron monotherapy.

Aprepitant- and Metoclopramide-Based Regimens Demonstrate Similar Efficacy in Preventing Delayed Cisplatin-Induced Emesis

June 27th 2014

For the prevention of nausea and vomiting after the first day of cisplatin-based chemotherapy, both aprepitant and metoclopramide when used in combination with dexamethasone were found to be similarly effective.

Declan Walsh, MSc, FACP, FRCP, on the Under-Diagnosis of Malnutrition

June 27th 2014

Declan Walsh, MSc, FACP, FRCP, director, 2014 MASCC/ISOO International Symposium, discusses the under-diagnosis of malnutrition in palliative medicine.

Alex Molasiotis, RN, PhD, on the Management on Breathlessness

June 27th 2014

Alex Molasiotis, RN, PhD, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer.

Dr. Roila on Aprepitant for the Prevention of Cisplatin-Induced Delayed Emesis

June 27th 2014

Fausto Roila, MD, chair, Medical Oncology Division, S. Maria Hospital, Terni, Italy, discusses an analysis of aprepitant for the prevention of cisplatin-induced delayed emesis.

Dr. Keefe Discusses Links Between Toxicities

June 27th 2014

Dorothy M. K. Keefe, MD, FRACP, past president, MASCC, director, SA Cancer Service, professor of cancer medicine, University of Adelaide, discusses links between toxicities associated with anticancer drugs.

Dr. Raftopoulos on Pulmonary Toxicity With EGFR TKIs

June 26th 2014

Haralambos Raftopoulos, MD, associate professor, Hofstra North Shore-LIJ School of Medicine, discusses pulmonary toxicity with EGFR tyrosine kinase inhibitors (TKIs).

Ã…ge Schultz, DVM, PhD, Discusses the Cost of Supportive Care Medicine

June 26th 2014

Ã…ge Schultz, DVM, PhD, executive director, Multinational Association of Supportive Care in Cancer (MASCC), discusses pain management and the cost of supportive care medicine.

Changing Treatment Landscape for RCC

June 25th 2014

Palliative Care for Patients With RCC

June 25th 2014

Role of TKIs in Oligometastatic RCC

June 25th 2014

PD-1 Inhibition in Renal Cell Carcinoma

June 25th 2014

Nivolumab in Renal Cell Carcinoma

June 25th 2014

Immunotherapy in Renal Cell Carcinoma

June 25th 2014

Second-Line Treatment Selection in RCC

June 25th 2014

First-line Therapy for Renal Cell Carcinoma

June 25th 2014

Treatment Considerations in Renal Cell Carcinoma

June 25th 2014

Treatment-Related Adverse Events in RCC

June 25th 2014

Alternative Dosing Schedules for Targeted Agents in RCC

June 25th 2014

Role of Cytoreductive Nephrectomy in mRCC

June 25th 2014